UNCLASSIFIED RENAL CELL CARCINOMA
Clinical trials for UNCLASSIFIED RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNCLASSIFIED RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for UNCLASSIFIED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy trial targets Tough-to-Treat kidney cancers
Disease control OngoingThis study is testing whether combining three medications—cabozantinib, nivolumab, and ipilimumab—can safely slow the growth of advanced kidney cancer that has spread. The trial will enroll about 60 adults with specific types of non-clear cell kidney cancer that cannot be surgica…
Matched conditions: UNCLASSIFIED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Bradley A. McGregor, MD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug duo targets Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing whether combining two existing cancer drugs, nivolumab and cabozantinib, is safe and effective for people with advanced non-clear cell kidney cancer that has spread. The trial will enroll about 60 adults who have had limited prior treatment to see if the com…
Matched conditions: UNCLASSIFIED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Head-to-Head kidney cancer drug trial seeks better control
Disease control OngoingThis study compares two existing drugs, cabozantinib and sunitinib, to see which is safer and more effective at controlling advanced kidney cancer that has spread. It is for patients with specific, less common types of kidney cancer. Participants are randomly assigned to take one…
Matched conditions: UNCLASSIFIED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Major trial aims to boost immune system to fight kidney cancer after surgery
Disease control OngoingThis large study is testing if adding an immunotherapy drug called nivolumab to standard kidney cancer surgery helps prevent the cancer from coming back. About 819 patients with kidney cancer that hasn't spread far will have surgery, with half also receiving the drug before and a…
Matched conditions: UNCLASSIFIED RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted radiation joins fight against bone pain in advanced kidney cancer
Disease control OngoingThis study is for people with advanced kidney cancer that has spread to their bones. It tests if adding a radioactive drug (radium-223) to a standard cancer pill (cabozantinib) works better than the pill alone. The main goal is to see if the combination can delay bone-related pro…
Matched conditions: UNCLASSIFIED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC